China’s Biomedical Edge: A New Regimen for Oesophageal Cancer
A Chinese clinical study demonstrates that a novel split-course chemoradiotherapy regimen, following induction chemo-immunotherapy, is both feasible and well-tolerated in patients with unresectable locally advanced…